Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
JBL Redefines Gaming Audio with Bold New JBL Quantum Series Lineup
-
Soleno Therapeutics Announces Publication of Results from Pivotal Study of VYKAT™ XR in the Journal of Clinical Endocrinology and Metabolism
-
ADP to Announce Second Quarter Fiscal 2026 Financial Results on January 28, 2026
-
AEye Sets the Pace for Lidar Industry by Announcing Stratos™ Ultra-Long-Range Third Generation Lidar Capable of Detecting Objects at up to 1.5 Kilometers
-
“Ampd Signal” Transforms Paid Social into a High-Performance Retail Growth Engine
-
New Study Reveals Shift in "Pizza Wars": Mid-Sized Chains Closing the Gap on Industry Giants
-
Marea Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
PKF O'Connor Davies Welcomes Bowman & Company
-
QuinStreet Closes Acquisition of HomeBuddy
-
Skylight and Hearth & Hand™ with Magnolia Debut Limited-Edition Digital Family Calendar Exclusively at Target
-
Deutsche Rohstoff AG: Early Warning Report Filed Pursuant to National Instrument 62-103 – Change in Equity Interests Below 10% in Almonty Industries Inc.
-
JBL Introduces New OpenSound Earbuds Designed for Environmental Awareness and Maximum Comfort
-
Viking Launches “The Viking Savings Event”
-
Routeware Brings Proven Industry Leadership to Fuel the Next Phase of Growth
-
Adtalem Global Education Announces Second Quarter Fiscal Year 2026 Conference Call
-
Coya Therapeutics Announces U.S. FDA Acceptance of Investigational New Drug (IND) Application for COYA 302 for the Treatment of Frontotemporal Dementia (FTD)
-
Starfighters Space Demonstrates Commercial Supersonic Flight Capabilities Through GE’s Aerospace Test Program
-
Curogen Awarded KDDF Research Grant, Attends the 2026 JP Morgan Healthcare Conference
-
OneNexus Announces Partnership with Travelers to Deliver Enhanced Surety Solutions for the Energy Sector
-
Fish & Richardson Elevates Dynamic 2026 Class of New Principals
-
CrowdStrike, AWS, and NVIDIA Select 35 Startups for the 2026 Cybersecurity Startup Accelerator
-
Landmark RESET-RA Study Published in Nature Medicine Demonstrates Durable Efficacy and Safety of the SetPoint System for Rheumatoid Arthritis
-
ALT5 Sigma Expects to File its Quarterly Report on Form 10-Q for the Third Quarter 2025 in the Coming Days
-
Diversified Healthcare Trust Provides Business Update
-
VerifyMe and Token Economy Leader Open World Announces Plan for Strategic Merger
-
Star Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12
-
Hybrid Works! CUPE Members at Ontario Health atHome Stage a Province Wide Day of Action on the First Day of Doug Ford’s Return to Office Mandate
-
IHOP Teams up With Malik Nabers to Transform Fantasy Football Setbacks Into a Celebration With the Launch of Bottomless Pancakes
-
Tidal Financial Group Announces Leadership Advancements as Part of Strategic Growth Plan
-
Feast & Fettle Makes Its Mid-Atlantic Debut in Washington, D.C., Maryland, and Virginia
-
John Baylouny Takes Reins as CEO of Leonardo DRS
-
AMERMIN Wins $11.5M Grant to Scale Breakthrough Critical Materials and Minerals Technology
-
Chips&Media and Visionary.ai Unveil the World's First AI-Based Full Image Signal Processor, Redefining the Future of Image Quality
-
PubMatic Launches AgenticOS, the Operating System for Agent-to-Agent Advertising
-
Curing the Incurable with ‘Biological Age Zero’ Cells: Clonell™ Launches the Ultimate Regenerative Medicine Platform
-
Subway® Canada Powers Up 2026 with Its New Fresh Fit Menu - Five Protein-Packed Sandwiches Under 500 Calories
-
Valens Semiconductor and Sakae Riken Kogyo Unveil e-Mirror with Order of Magnitude More Imaging Data via MIPI A-PHY
-
GE HealthCare to announce fourth quarter and full year 2025 results on February 4, 2026
-
JBL Expands Its Iconic Endurance Line with Five New Models Built for Peak Performance
-
AerCap Holdings N.V. to Release Fourth Quarter 2025 Financial Results on February 6, 2026
-
Dechra Announces FDA Approval of Zygolide® (pergolide tablets) for the Control of Clinical Signs Associated with Pituitary Pars Intermedia Dysfunction (Equine Cushing’s Disease) in Horses
-
Slingwave Brings AI-Powered Unified Measurement to eCommerce and DTC Brands
-
Kenai Therapeutics Receives $8M Grant from California Institute for Regenerative Medicine (CIRM) to Advance RNDP-001 for Treatment of Idiopathic Parkinson's Disease
-
Talcott Financial Group Launches Three New Fixed Annuity Products to Meet Growing Retail Demand for Secure Retirement Income
-
DIRECTV FOR BUSINESS® Launches Streaming TV Solution For Small Businesses
-
JBL Debuts Its First OpenSound Earclips that Transform Everyday Audio Into a Must-Have Accessory
-
Auto Dealer Sentiment Turns Positive in 2025 as Survey Reveals Profit and Valuation Expectations Improve for the First Time Since 2021
-
Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules
-
Scholar Rock to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
PMSI Promotes Veteran Mortgage Banking Executive Jeff Choi to COO
